Related Experiment Video
Updated: Apr 29, 2026

11:48
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
12.5K
Biochemical defects in minor spliceosome function in the developmental disorder MOPD I
Faegheh Jafarifar1, Rosemary C Dietrich1, James M Hiznay1
1Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Summary
Mutations in the RNU4ATAC gene cause MOPD I by impairing the U4atac snRNA
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- Biallelic mutations in the RNU4ATAC gene cause MOPD I/TALS, a developmental disorder.
- Nine RNU4ATAC mutations are known in MOPD I patients, all potentially affecting U4atac snRNA function and minor intron splicing.
- The precise molecular mechanisms underlying these effects remain unclear.
Purpose of the Study:
- To elucidate the molecular basis of MOPD I/TALS caused by RNU4ATAC mutations.
- To investigate how specific RNU4ATAC mutations impact U4atac snRNA expression, protein binding, and complex formation.
- To understand the link between these molecular defects and impaired minor intron splicing in patient cells.
Main Methods:
- In vitro and in vivo assays to assess U4atac snRNA expression and protein binding.
- Analysis of MOPD I patient fibroblasts and induced pluripotent stem cells (iPSCs).
- Glycerol gradient sedimentation and immunoprecipitation to study snRNP complex formation.
Main Results:
- One mutation (124G>A) significantly reduced U4atac snRNA expression.
- Four mutations (30G>A, 50G>A, 50G>C, 51G>A) impaired the binding of essential proteins to U4atac snRNA.
- Cells with the common 51G>A mutation showed reduced levels of the U4atac/U6atac.U5 tri-snRNP complex.
- Inefficient splicing of U12-dependent introns in patient cells was linked to defects in minor tri-snRNP formation.
Conclusions:
- RNU4ATAC mutations disrupt multiple aspects of minor snRNA function, including expression, protein association, and complex assembly.
- Defects in minor tri-snRNP formation underlie the inefficient splicing observed in MOPD I patient cells.
- This study establishes a mechanistic basis for MOPD I/TALS, linking RNU4ATAC mutations to specific molecular defects in the minor spliceosome.
Related Concept Videos
Alternative RNA Splicing
20.4K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.4K
RNA Splicing
53.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
53.3K
RNA Splicing
15.9K
15.9K
ATP Synthase: Mechanism
15.9K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.9K
Myasthenia Gravis ll: Pathophysiology
49
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
49
Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K

